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E-mail address: gingras@lunenfeld.ca (A.-C. GingraThe past 10 years have witnessed a dramatic proliferation in the availability of protein interaction
data. However, for interaction mapping based on afﬁnity puriﬁcation coupled with mass spectrom-
etry (AP-MS), there is a wealth of information present in the datasets that often goes unrecorded in
public repositories, and as such remains largely unexplored. Further, how this type of data is repre-
sented and used by bioinformaticians has not been well established. Here, we point out some com-
mon mistakes in how AP-MS data are handled, and describe how protein complex organization and
interaction dynamics can be inferred using quantitative AP-MS approaches.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. The hairball: representation of protein–protein interactions
The availability of cDNA and Open Reading Frame (ORF) collec-
tions [1–7] and yeast strains engineered to express epitope-tagged
proteins [8] ﬁrst allowed us to begin to characterize at a global le-
vel how proteins associate with one another. In 1989, Fields and
Song published the ﬁrst yeast two hybrid (Y2H) manuscript [9],
introducing an approach which has now been employed to gener-
ate large-scale interaction maps in multiple organisms, including
yeast [10–13], worms [14,15], ﬂies [16–18], humans [18–21] and
plants [22,23]. Y2H maps ushered in a new era in the ﬁeld of pro-
tein–protein interactions, and changed the type of question that
we can pose: instead of asking ‘‘Does protein A interact with pro-chemical Societies. Published by E
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s).tein B?’’, or even ‘‘What does protein A interact with?’’, it has be-
come ‘‘How is the cell wired?’’
Y2H primarily detects direct protein–protein interactions (here
referred to as binary interactions), and a simple representation of
such an interaction between two proteins consists of drawing
two circles (or nodes) linked by a line (or edge; Fig. 1A). Each de-
tected interaction can be displayed in the same fashion, and com-
bined to generate a map of the protein–protein interaction
network (or interactome; Fig. 1B). These types of representations
– and their analysis by computational biologists – are extremely
useful, allowing for the study of the organization of any given sys-
tem, and such ‘‘hairballs’’ also allow for hypothesis generation
regarding the biological function of the proteins under analysis.
While Y2H is probably the most cost-efﬁcient binary approach
for proteome-wide surveys, other techniques optimized for the
detection of direct interactions also exist (for review, see
[24,25]). Data from these methods can be depicted and analyzed
using the same type of graphical representation.
Parallel to the development of Y2H and other types of binary
approaches, dramatic improvements in instrumentation have en-
abled the efﬁcient coupling of afﬁnity puriﬁcation to mass spec-
trometry (AP-MS) for the identiﬁcation of protein–protein
interactions. Proteome-wide surveys of the interactome are still





Figure 1. Graphical representations of protein interactions. (A) Graphical repre-
sentation of a direct protein–protein interaction. The two circles (referred to as
‘‘nodes’’) represent each of the proteins engaged in an interaction, and the line
linking them (the ‘‘edge’’) represents the interaction. (B) Interaction network (or
‘‘hairball’’) representing 500 interactions amongst 100 proteins (generated by
Cytoscape [103]). (C) Protein complexes in a cell. Here, the green protein is found in
three different biochemically deﬁned complexes (direct interactions are depicted
by contact between the nodes). Not shown here is the relative abundance of these
three complexes. (D) Unweighted graphical representation (spoke expansion) of the
interactions established by the green protein after afﬁnity-puriﬁcation coupled to
mass spectrometry. The organization in different complexes is lost (from this single
AP-MS analysis) and direct and indirect interactions are represented in the same
manner, as they are indistinguishable in the mass spectrometer. (E) Iterative AP-MS
helps to resolve complex organization surrounding a central bait. After identiﬁca-
tion of each of the interaction partners for the green protein, these can be in turned
cloned, and analyzed by mass spectrometry. This recapitulates the complex
organization shown in (C), though it does not indicates direct or direct interactors.
(F) Adding binary data to AP-MS data is beneﬁcial to reconstitute the assembly of
individual complexes. The dashed lines represent demonstrated (thickest lines) or
predicted (thinner lines) direct interactions (the likelihood of a direct interaction is
proportional to edge thickness). (G) Complexes are not always present in the cell in
the same abundances; here, complex 1 is more abundant than complex 2, itself
more abundant than complex 3. Most of the green protein will reside in complex 1.
(H) Quantitative mass spectrometry data provides the relative abundance of each of
the interactors for the green protein. This information is shown here as the
thickness of the edges.
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sects, plants and various pathogens [30–46] indicate that reconsti-
tution of near ‘‘complete’’ AP-MS interactome maps is not only
possible, but likely, in the near future. Importantly, however, the
interactions detected by AP-MS differ from those obtained via
Y2H, in that they represent a mix of direct and indirect binding
relationships. For proteins that take part in multiple alternative
complexes (a very common occurrence), the interactors identiﬁed
in such an analysis thus represent a mixture of multiple protein
machines (Fig. 1C and D). While techniques such as high-densityiterative mapping of protein complexes, the use of quantitative
mass spectrometry tools, or binary approaches such as Y2H, can
be used to decipher this information (see below), how these types
of interactions are depicted and analyzed remain as important
challenges to be solved, as it is a priori not always possible to dis-
tinguish direct versus indirect interactions in MS data.
In most cases, the same type of network representation used for
Y2H (i.e. nodes linked by edges) has been utilized to depict inter-
actions discovered using AP-MS approaches. However, the mean-
ing of edges in AP-MS data is not always clear, as both direct and
indirect interactions are similarly represented. Computationally,
there has also been much confusion regarding whether to simply
draw edges between a bait and all of the interactors detected in
the mass spectrometer (referred to as a ‘‘spoke’’ expansion), or to
assume that all identiﬁed components of an afﬁnity puriﬁcation
are part of a single complex, and draw edges between all prey pro-
teins associated with a given bait (a ‘‘matrix expansion’’). The ma-
trix expansion model is particularly problematic, in that it
completely ignores the partitioning of a bait into mutually-exclu-
sive protein complexes (which may have completely different bio-
logical roles; Fig. 1C and E), and improperly implies a series of
relationships that may never exist in a cell. Fortunately, this type
of expansion method is used less and less.
There is also signiﬁcant confusion in protein interaction dat-
abases regarding how to record, annotate and display AP-MS data.
For example, IntAct [47] (currently the largest primary repository
of mammalian AP-MS experiments, to our knowledge) records
AP-MS data by indicating a single ‘‘interaction number’’, which
encompasses the bait and its interactors as reported by the authors
of individual studies. To display this data in a consistent manner, a
spoke expansion method is used to record bait–prey relationships,
and to display them for a single query (see Fig. 1D). The IntAct site
however warns that ‘‘most interactions generated by spoke and ma-
trix expansion result in false positives’’, and offers a convenient op-
tion to ‘‘ﬁlter’’ them. This – sadly – only leads to more confusion.
For example, in our own dataset on the interactions established
by the Ser/Thr phosphatase PPP4C, we deposited both AP-MS data
(which is ﬁltered out by the spoke expansion ﬁlter), and a conﬁr-
mation of these interactions by immunoprecipitation followed by
immunoblotting (IP/Western) on the same samples [48,49]. Sur-
prisingly, the IP/Western data survive the ﬁltering process, and
are considered to be ‘‘binary’’ data. This is highly problematic be-
cause biochemically, the IP/Western data are just as likely as the
AP-MS data to be mediated by bridging proteins, yet because the
detection method is actually more biased (in that here we only
queried for the presence of a single prey with a speciﬁc antibody),
the interactions are treated differently. This is clearly not the best
way to think about interaction data. Importantly, this problem is
not limited to IntAct, which actually provides very careful curation
of experimental data, enabling us to track down such issues (and
we have worked with IntAct to properly annotate our own exper-
iments). Adding to the confusion, some AP-MS data have been
deposited by the authors as a set of ‘‘binary’’ interactions (i.e. they
were pre-expanded using the spoke model [43]), and are therefore
not ﬁltered out by the spoke and matrix expansion ﬁlters in IntAct.
Other repositories use different rules for annotation and display of
interaction data [50]; e.g. BioGRID annotates all interactions in a
binary spoke-expanded [51] manner, while HPRD sometimes just
reports ‘‘complexes’’ [52]. Given that database aggregators and
computational biologists often download entire datasets from pub-
lic repositories without being aware of the underlying nature of the
data, this confusion can lead to spurious conclusions regarding
protein–protein interactions.
It is important to note that several of the commonly employed
‘‘binary’’ approaches can also detect both direct and indirect inter-
actions, yet because the detection method is ‘‘single channel’’ (that
AB
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Figure 2. Strategies for quantiﬁcation of AP-MS data. (A) Absolute quantiﬁcation
with isotopes; alternative sources of isotopically labeled peptides are indicated. In
all cases, the absolute concentration of the standards must be determined prior to
use in mass spectrometry. (B) General principle behind the use of isotopic labels in
quantitative proteomics. In the precursor (MS1), the mass to charge ratios (m/z) of
all co-eluting peptides are monitored, and their intensity recorded. Since isotopi-
cally labeled peptides have different m/z, they are distinguished from each other in
the MS1 scan: Relative differences in abundance are proportional to their
intensities. Identiﬁcation (here of the light, green, species) is performed in the
MS/MS (or MS2) spectrum. (C) Quantiﬁcation based on spectral counting. Different
unique peptides from the same protein may be sequenced; spectral counts refers to
the sum of all spectra mapped to a given protein.
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have a reagent for detection), the methods are optimistically
thought to be ‘‘binary’’. For example, any experiment in which pro-
teins are expressed in their host of origin (or a closely related spe-
cies) is susceptible to recovering both direct and indirect
interactions, but this fact tends to be ignored.
Simply put, spoke expansion of AP-MS data does not generate
false-positives, if the data are handled correctly. If the mass spec-
trometry and data analysis have been conducted properly, these
types of protein identiﬁcations are actually of very high quality:
what they do not tell you is that an interaction is direct. A better
understanding by computational biologists and experimentalists
alike of what the edges in AP-MS actually represent is thus critical
moving forward. Rather than debating whether an indirect interac-
tion is a false positive, we suggest that it would be more useful to
clearly highlight those interactions that have been demonstrated
to be direct (using one or more methods outlined below), and to
make this data more easily available for interactome analysis.
Alternatively, calculating the probability of a direct interaction
(based, for example, on future benchmarking of ‘‘binary’’ methods
such as Y2H) and overlaying this information on AP-MS data would
allow for a much better understanding of the molecular organiza-
tion of protein complexes. Visualization of the AP-MS interactions
amongst all nodes of a network superimposed onto proven direct
binding interactions (Fig. 1F and see below) would provide much
higher information content to interactome maps.
In summary, while true binary approaches are easily repre-
sented by a node-edge-node relationship (and annotated as such
in interaction databases), how data generated by AP-MS are
recorded, visualized and distributed to the research community re-
mains somewhat problematic. As MS instrumentation increases in
speed and sensitivity, the use of AP-MS is also increasing apace. A
concerted effort by biologists, curators and bioinformatics experts
will be required to address this important issue.
2. The use of quantitative data in interaction mapping
Most graphic representations of Y2H binary data tend to be un-
weighted; i.e. all edges possess the same value. If value is added to
these types of edges, it is most often based on conﬁdence in the
detection of the interaction (e.g. signal strength in a screen). These
scores can be very useful (see in particular a conﬁdence score
developed by Braun et al. based on reproducibility of the detection
of an interaction across several orthogonal binary assays [25,53]),
but they do not directly translate to a likelihood of interaction in
a physiological context. Another important issue in our ﬁeld is that,
similar to most Y2H maps, AP-MS network edges are often also
represented as being of equal weight, with little consideration for
the conﬁdence in each putative interaction or the relative abun-
dance of the interaction partners. We and others have developed
new methods to use quantitative information embedded in mass
spectrometry data to assist in the identiﬁcation of true positives
in interaction maps [30,33,38,54–58], and such information can
very effectively be used to calculate absolute or relative differences
in the abundance of proteins across multiple samples, and to better
understand protein complex topology (Fig. 1G and H). Excellent re-
views on quantitative mass spectrometry applied to protein com-
plexes have been published recently [59–61]; here we will refer
only to quantiﬁcation as it applies to topology and stoichiometry,
with a short discussion of interaction dynamics.
Absolute quantiﬁcation of proteins in a given sample can be
determined using isotopically-labeled ‘‘heavy’’ peptide or protein
standards. Such peptides are commercially available [62], and
can be spiked into any sample of interest prior to MS analysis
(Fig. 2A). Since the mass spectrometer measures mass/charge (m/
z) ratios, these standards are easily distinguished from the ‘‘light’’endogenous counterparts in the sample (Fig. 2B). Alternatively, re-
combinant proteins can be expressed and isotopically labeled (e.g.
with 15N or heavy amino acids [63]) in-house, then spiked into a
sample prior to proteolysis. A third variation of this approach in-
volves a recombinant, isotopically labeled concatenated polypep-
tide sequence derived from multiple proteins of interest
(qConCat [64,65]). Ideally, several standard peptides derived from
each protein of interest should be used for quantiﬁcation (to pre-
vent hidden biases that can arise from, e.g. post-translationally
modiﬁed peptides in one condition and not another). While most
researchers would agree that using isotopically-labeled standards
is ideal for accurate quantiﬁcation, this may not be practical for
large-scale AP-MS studies, both due to the cost of large numbers
of standards, and various technical difﬁculties, especially in deter-
mining the quantity of each standard to be added to each sample to
cover a broad dynamic range of protein concentrations across mul-
tiple experiments. For example, when a given protein is used as a
bait, its abundance in the AP may be several 100-fold higher than
when it is isolated as an interactor with another bait. The proper
concentration of each standard peptide must be tuned in each case
to ensure that it is present at amounts within the linear range of
the mass analyzer.
A number of alternative approaches have been developed to as-
sess protein abundance. One simple, yet surprisingly effective
strategy, is to monitor spectral counts (simply the number of mass
2726 A.-C. Gingras, B. Raught / FEBS Letters 586 (2012) 2723–2731spectra assigned to each protein; Fig. 2C) to model the abundance
of interactors across parallel puriﬁcations [38,66–68]. Spectral
counts are most often normalized to protein length (since larger
proteins yield more peptides, they tend to generate more spectra
at the same molarity), and sometimes to the expression levels of
the bait itself. Spectral counts can be used for ﬁltering out noise
in AP-MS experiments, but also to compare the recovery of the
same prey across samples [67]. Importantly, spectral counts are
more reliable for proteins in the medium to high abundance range
in a sample, but are not as useful for low abundance polypeptides.
More accurate quantiﬁcation that does not require isotopes can be
performed by analyzing the intensity of the signal in the precursor
scan of the mass spectrometer (here referred to as the MS1 scan),
or the intensity of the product ions after fragmentation (MS/MS
or MS2 scan). Similar to spectral counts, MS1 quantiﬁcation has
been used to identify true positives in AP-MS data, and in some
cases to compare the samples quantitatively [58,69,70]. However,
since different peptides ionize differently in the mass spectrometer
(i.e. ion intensities for different peptides at equimolar concentra-
tions can vary widely), these methods can only provide an estima-
tion of abundance (although these issues decrease as the counts or
intensities of more peptides from the same protein are averaged;
see e.g. [71]). To circumvent this problem, while keeping overall
costs of the experiment more manageable, Wepf et al. devised an
approach in which the recombinantly expressed ‘‘bait’’ protein is
fused to an epitope tag that can be used both for isolation and
quantiﬁcation [72]. A single heavy isotopic standard corresponding
to a peptide in the epitope tag is spiked into samples to establish a
quantitative reference point for the bait in each experiment. Com-
putational analysis can then be used to quantify each protein pre-
viously used as a bait across multiple experiments. This approach
is more useful when looking at interconnected networks, such that
each prey in the dataset is also analyzed as a bait. An extension of
this type of approach could consist of spiking a general mixture of
heavy peptides into each AP, where some correspond to the epi-
tope tag, some to common contaminants, and others correspond
to various components of the network under study, and using
these as beacons for quantiﬁcation of the entire interaction net-
work. While this has not (to our knowledge) been used for interac-
tion proteomics, similar strategies have been applied in the ﬁeld of
biomarker detection [73].
Unfortunately, at present much of this type of data in proteo-
mics experiments is essentially ignored. For example, abundance
measures are stripped out of interaction data recorded in the major
interaction databases, and in most cases, conﬁdence values are also
not tracked. As such, major and minor interactors are given equal
weight in such datasets. This is problematic because it enhances
the disconnect between small scale and large scale studies, and
prevents access to new types of information for modeling by com-
putational biologists. This being said, since abundance levels may
vary depending on the experimental set-up, it will be challenging
to harmonize quantitative data deposited from different sources.
3. From interactor lists to complexes
A single AP-MS analysis reveals little regarding the supramolec-
ular architecture of individual protein complexes, but this tech-
nique can be harnessed in multiple ways to reveal how protein
machines are assembled. For example, the composition of a given
complex, and multiple mutually-exclusive assemblies, can often
be deduced by performing iterative ‘‘high density’’ AP-MS [74], in
which each of the preys from one round of analysis become baits
in the next round (Fig. 1E). This is clearly somewhat labor-inten-
sive, but the use of incomplete data (e.g. when not all proteins in
a complex are analyzed as baits, or if any of the preys fall below
the detection limit) can result in the over-ﬁtting of complex com-position and a loss of biologically important information. For
example, when we characterized the STRIPAK (STRiatin Interacting
Phosphatase And Kinase) complex, 10 different protein families
were identiﬁed as bona ﬁde components. Only after performing
AP-MS on each of the components were we able to deﬁne two
independent molecular entities in the pulldowns: one complex
associated with the cortactin binding protein 2 (CTTNBP2), and a
second complex containing the proteins SLMAP and SIKE [34].
An alternative to reciprocal AP-MS that to date has been used
only in smaller scale studies is to combine the standard AP step
with an orthogonal approach to separate multiple bait-containing
complexes; this may be accomplished e.g. via gel ﬁltration chroma-
tography or other standard chromatographic steps followed by AP-
MS [75]. Despite obvious advantages, this approach has not gener-
ally been applied to large-scale AP-MS analysis, most likely due to
the additional analytical steps required (e.g. tracking down the
fractions in which the bait partitions) and increased analysis time.
Approaches such as Blue Native gels have been combined effec-
tively with AP-MS for the analysis of membrane-associated protein
complexes [76,77], and it is likely that such studies will be ex-
panded in the near future. In recent years, parallel (and still largely
unpublished) efforts from several groups have attempted to forego
the AP step completely, and to systematically analyze protein com-
plexes by chromatographic fractionation coupled to mass spec-
trometry (Foster, pers. comm.). Although the dynamic range and
limitations of this approach are not entirely clear at present, it
could represent a very useful companion to AP-MS analysis to en-
able the detection of mutually exclusive complexes containing a gi-
ven protein. Furthermore, as discussed below, this type of
approach could be very useful in mapping global changes in inter-
actomes imparted by a stimulus, drug or other perturbation.
An obvious limitation to the use of AP-MS to identify and char-
acterize protein complexes is that the complex must be soluble in
the buffer used for afﬁnity puriﬁcation and the interactions must
withstand the afﬁnity puriﬁcation step. Simply put, if a bait protein
and its interacting partners are not extracted efﬁciently during ly-
sis, they will not be observed by the mass spectrometer. For exam-
ple, proteins associated with chromatin are often found in the
pellet after centrifugation of the crude lysate, unless steps to shear
the DNA (such as sonication or treatment with nucleases) are in-
cluded in the lysis protocol [78–80]. Similarly, membrane proteins
are typically poorly recovered in standard extraction buffers,
though employing different detergents for their extraction has re-
cently enabled the recovery of multiple complexes associated with
different membranes [81–85]. Systematic studies in S. cerevisiae to
deﬁne the chromatin-associated interactome [79] and the interac-
tome of all membrane-localized proteins (Greenblatt, pers. comm.)
indicate that these types of approaches will lead to a greatly ex-
panded view of the interactomes for proteins previously thought
to be inaccessible to AP-MS analysis. To better understand interac-
tions that do not withstand the afﬁnity puriﬁcation step (often re-
ferred to as ‘‘transient’’ interactions, but more accurately deﬁned as
interactions that have a fast ‘‘OFF’’ rate in solution) a variety of dif-
ferent strategies will most likely be required. That these types of
interactors do in fact exist has been deﬁned by quantitative proteo-
mics with SILAC, in which combining samples at different times
(prior to lysis, after lysis, or after afﬁnity puriﬁcation) revealed
interactions that are stable in solution, and interactors that ex-
change rapidly [86–88]. The simplest approach to capture rap-
idly-dissociating interactors is to decrease the chances for the
interactions to be lost in the ﬁrst place. For example, in a dual puri-
ﬁcation protocol such as Tandem Afﬁnity Puriﬁcation (TAP), a pro-
tein with a fast off rate has the chance to dissociate from its
interactors in each of the two puriﬁcation steps (and during the
proteolysis and wash steps). Using a single step puriﬁcation meth-
od, accompanied by shorter incubation times and limited washes,
A.-C. Gingras, B. Raught / FEBS Letters 586 (2012) 2723–2731 2727can help to maintain interactors that would otherwise be lost
[48,89]. While these types of samples are likely to contain a larger
numbers of contaminants, the use of improved software for statis-
tical analysis of putative interactors (e.g. SAINT and similar tools
[30,33,38,54–58]) allows for efﬁcient discrimination between con-
taminants (e.g. proteins that bind to the solid phase support or
antibody) and bona ﬁde interactors.
Whilemore sensitiveMS instruments, an increase in the speed of
bait isolation, fewerwash steps, and smarter software have dramat-
ically improvedour ability to identify interactingpartners, this pipe-
line will probably not be sufﬁcient to maintain all interactions;
alternative strategies, most often making use of crosslinking re-
agents that can be applied directly to cells prior to lysis, can also
be exploited (see, e.g. [35]). It must be stated that each of the
approaches described above has advantages and caveats, but – per-
formed under well-controlled conditions – have the potential to
greatly expand the detection of protein–protein interactions by
AP-MS.
4. Mapping topologies
All of the approaches highlighted above are aimed at deﬁning
protein complexes in the biochemical sense: i.e. providing a ‘‘parts
list’’ of complex composition. Understanding how these parts are
assembled into a functional unit is also clearly important. In a
best-case scenario, information from binary approaches (e.g.
Y2H) may already be available, and used to model protein complex
topology. Crosslinking followed by mass spectrometric identiﬁca-
tion of the crosslinked residues in protein partners is also increas-
ingly used (for reviews, see [90–94]). Since this approach also
identiﬁes likely direct interactions, crosslinking data could easily
be integrated within the networks generated by AP-MS to identify
some of the topological elements (Fig. 1F).
It is also possible to use ‘‘binary’’ approaches to systematically
test for direct interactions between proteins detected by AP-MS.
To determine the viability of such an approach, we have tested sev-
eral different methods. Using Y2H, we performed a pilot re-scoring
of1000 high-conﬁdence AP-MS interactions (Braun, pers. comm.).
This assay yielded a fairly low (<10%) validation rate, likely due to a
combination of false negatives in Y2H (where assay sensitivity is
25% [53]), indirect interactions identiﬁed by AP-MS, and perhaps
false positives in AP-MS. Combined with the tedious cherry-picking
required for assembling the large number of individual protein pairs
for such an analysis, this methodmay not be the most efﬁcient way
to identify direct interactions in an AP-MS dataset, especially since
genome-wide screens by Y2H are underway and should in theory
test all possible pairs. In another study, we used LUMIER [95] to test
50 baits against a total of 600 interacting proteins, in an attempt to
identify direct interactions in a single high-conﬁdence interaction
network (Taipale, pers. comm.). LUMIER monitors the recovery of
a luciferase-tagged bait protein with a FLAG-tagged prey, following
immunoprecipitation. LUMIER validation was more successful than
Y2H, although the percentage of interactions that are truly direct in
the LUMIER assay is unclear (in this method, two proteins are
co-expressed in a human cell line, and could therefore be bridged
by one or more additional endogenous proteins). Finally, in a much
smaller test case, we successfully identiﬁed direct protein–protein
interactions by programming reticulocyte lysates to express nuclear
proteins, which are normally not expressed in red blood cells. Here,
we demonstrated that the catalytic subunit of PP4 interacts directly
with PP4R2, and that this dimer was necessary for the recruitment
of a third member of the complex, PP4R3 [49]. In this case, all
interactions were also recapitulated by Y2H [49].
It may also be possible to retest AP-MS interactions to look for
direct interactors by employing assays with a strong bias for close
proximity, using methods such as protein fragment complementa-tion (PCA [96,97]); the use of ﬂuorescent proteins for PCA has the
added advantage of providing information regarding the subcellu-
lar location in which the interaction takes place.
Ideally, retesting could also be done using puriﬁed proteins
from a phylogenetically distant host (e.g. a bacterial expression
system for eukaryotic proteins); to date, this is widely considered
to be the gold standard for the identiﬁcation of direct protein–pro-
tein interactions. With the availability of cDNA and ORFeome col-
lections, and the ongoing construction of protein collections [98–
101], systematic retesting of proteins by expression in bacteria
(or other hosts) may be scaled-up. While this type of testing can
certainly be done using standard pull-down experiments and
SDS–PAGE, protein array technologies [102,103] could afford high-
er throughput. However, some difﬁculties remain with testing
interactions using bacterially expressed recombinant proteins:
e.g. many classes of proteins are not easily expressed (especially
as full length polypeptides), and interactions which require, for
example, a post-translational modiﬁcation may be missed using
this method. In summary, while it is not yet clear which of the ap-
proaches mentioned above (or others) may be the most efﬁcient
for providing information about direct interactions in AP-MS data
to better understand the architecture of protein complexes, there
are a number of possibilities that are becoming increasingly avail-
able. Furthermore, as high throughput mapping efforts using many
different approaches continue, merging of datasets may eventually
provide much of this information.
As an alternative to the use of external data sources, it is possi-
ble in some cases to map the organization of protein complexes
using quantitative MS data as a proxy. For example, if a bait protein
retrieves only a single high abundance interactor and many lower
abundance interactors, it is unlikely that the high abundance inter-
action partner is bridged by another protein. In a similar way, if an
interactor remains associated with the bait under conditions
where most of the other interactors are displaced (e.g. by increas-
ing the stringency of the washes), it is more likely to be a direct
binding partner than an indirect interactor. An alternative is to
progressively dissociate protein interactions in the mass spectrom-
eter; this has been done for several large complexes, including the
multisubunit translation initiation factor eIF3 [104] (for recent re-
views of MS of intact complexes, see [92,105]).
To better understand protein complex topology, it can be infor-
mative to place additional focus on putative scaffolds in a given
dataset. For example, based on quantitative MS data we postulated
that the striatin molecule could act to bridge the phosphatase
(PP2A) and kinase (a family of Sterile 20 kinases known as GCKIII)
components of the STRIPAK complex. To explore this hypothesis,
we performed AP-MS on a series of epitope-tagged striatin trunca-
tion mutants [106]. This and subsequent studies indeed revealed
that striatin is a scaffold, but that the kinase is likely recruited to
the phosphatase via the CCM3 protein (mutated in cerebral
cavernous malformations) [107]. To conﬁrm this model, we immu-
noprecipitated the kinase and analyzed by quantitative mass spec-
trometry the recovery of interaction partners, following the
depletion of CCM3 and striatin by RNAi. A similar approach – using
genetic deletion in S. cerevisiae – was employed by the Washburn
group to deﬁne the network architecture of both the SAGA and
ADA chromatin remodeling complexes [108], and the Rpd3 histone
deacetylase complex [109]. Despite potential complicating issues
(e.g. the expression level of a given protein may be inﬂuenced by
the absence of interacting partners), this type of approach – espe-
cially in the context of modern quantiﬁcation methods – offers
great promise for the systematic analysis of complex topologies.
In the case of S. cerevisiae, the approach consists of simply trans-
forming a plasmid coding for the protein of interest into a relevant
strain, or crossing strains in which endogenous proteins have been
epitope tagged to strains in which a single complex component has
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conducted in a large-scale, automated fashion). In human cell sys-
tems, the limiting factor (at least in our hands) is the establishment
of stable cell lines expressing tagged bait proteins: though still
relatively expensive, transient knock down of suspected direct
interactors is now robust, and enables the global analysis of
protein complex organization.
We also note that – while not directly performed in the exper-
iments described above – the inclusion of absolute peptide or
protein standards within this type of framework may be extremely
useful for elucidating the stoichiometry of components of a given
complex. In this respect, the concatenated peptide strategy
(qConCAT) mentioned above is particularly appealing, as each of
the peptides in the qConCAT are present at identical molarities,
thereby enabling determination of the molecular stoichiometry
for multiple proteins in a complex. Using such approaches, we
were able to determine that striatin is likely present as a trimer
within STRIPAK (Kean et al. unpublished).
5. One interactome to many
While we have discussed some approaches to enable the inte-
gration of quantitative information into large-scale AP-MS interac-
tion maps, we have not discussed what these maps actually mean.
The majority of protein–protein interaction maps have been gener-
ated under a single physiological condition, and usually in only one
organism or cell line, resulting in a steady-state (or static) interac-
tome. For example, the bulk of the data currently available from
medium or high-throughput human interactomes have been gen-
erated from derivatives of the HEK293 cell line (a smaller number
of experiments have employed other immortalized cell lines). This
concerted focus on a single cell line does have advantages in terms
of benchmarking interactomes from different research groups, and
in establishing a baseline for a draft map of a complete interactome
in a human cell. However, there are clearly many interactions
which may not be detected under these conditions, e.g. because
certain proteins are not expressed in these cells (e.g. the PP2A
inhibitor CIP2A is upregulated in certain cancer cells, making its
detection easier [110]). We may also miss interesting protein–pro-
tein interactions that occur only after exposure to certain hor-
mones, growth factors or stresses, only during apoptosis, only in
highly conﬂuent cells, or only during a given developmental stage.
Standard AP-MS methods can also miss interactions that occur
with; (i) membrane proteins, because buffer conditions that liber-
ate proteins from membranes are often not compatible with main-
taining protein–protein interactions in solution, and (ii) amongst
chromatin-associated proteins that can be pelleted with the DNA
during lysate preparation. As such, it is unclear what fraction of
physiologically-relevant interactions will ultimately be identiﬁed
by current efforts to systematically map protein–protein interac-
tions in one cell type, and under one condition.
There has been an increase in efforts to produce more ‘‘dy-
namic’’ views of interactomes using AP-MS. (The LUMIER approach
mentioned above was also designed with this type of analysis in
mind, and can be used to monitor changes imparted by signaling
events [95]). Systematic methods to map dynamic changes include
the use of isotopic labeling approaches, and increasingly, quantiﬁ-
cation based on spectral counts [31,35] or ion intensities of precur-
sor peptide (MS1) or fragment ions (MS2). As quantitative methods
and the accompanying software become more robust, there will be
a major increase in interaction maps comparing cell- or tissue-spe-
ciﬁc interactions, or attempts to address changes in subsets of a
network. It is not realistic to expect that every possible protein
product will be monitored across all cell types (or tissues), or fol-
lowing treatment with every stimulus. However, as data become
increasingly available regarding the function of each of the pro-teins encoded in a genome (e.g. via systematic RNA interference
screens), and as the transcriptomes and proteomes of various cell
types and tissues become known, cell types and screening condi-
tions can be speciﬁcally selected based on the biological process
of interest. For example, Glatter et al. were interested in deﬁning
the interaction network surrounding the insulin receptor/target
of rapamycin pathway in Drosophila, and therefore proﬁled interac-
tions in Kc167 cells following insulin stimulation using a spectral
count based label-free approach [35]. Their study, in addition to
identifying new components of the pathway, revealed that 22%
of the detected interactions were regulated by insulin. A spectral
count-based approach was also utilized by Li et al. to map interac-
tion network dynamics regulating interferon production, centered
on 58 known innate immunity regulators. This work revealed
20% regulated interactions (following treatment with mimics of
infection), and enabled them to establish the role of Mind Bomb
proteins in the anti-RNA viral innate immune response [111]. Ba-
ker et al. employed a SILAC approach to reveal light-modulated
interactions with the circadian clock protein FRQ in Neurospora
[112]. To begin identifying cell fate decisions speciﬁed by the
ERK kinase, and its dynamically-regulated interactors, von Kriegs-
heim et al. employed a SILAC approach to quantify interactors in
rat PC12 cells stimulated for different times with nerve growth fac-
tor (NGF) or epidermal growth factor (EGF). This work revealed key
differences between protein–protein associations modulated by
the two different growth factors [113].
Lastly, while the quantitative approaches described above use
spectral counting or SILAC for quantiﬁcation, another quantiﬁca-
tion method that is gaining in popularity in the proteomics com-
munity exploits quantiﬁcation of the product ions in MS2
spectra. In the standard approach known as selected reaction mon-
itoring (SRM) [114–116], a prerequisite for quantiﬁcation is to
establish a robust list of peptides and product ions (these pairs
are called transitions) to be recorded and quantiﬁed. Although
the set-up phase of an SRM assay is time-consuming, once in place,
the assay is rapid and extremely sensitive. Recently, Bisson et al.
combined afﬁnity puriﬁcation with SRM (in a modiﬁed approach
they call AP-SRM), and used it to better understand membrane-
proximal phosphotyrosine signaling events by performing quanti-
tative proteomics in HEK293T cells stimulated with EGF and other
growth factors. Due to the combination of low cost per sample,
sensitivity and accuracy, AP-SRM has great potential to enable
the generation of time-resolved interactomes (e.g. Bisson et al.
looked at six times points after EGF treatment) and to screen con-
dition-speciﬁc interactions (in this case, six different growth fac-
tors). However, AP-SRM also has drawbacks, ﬁrst in the need to
optimize the quantiﬁcation method (i.e. select the transitions to
follow), but more importantly, the fact that one can only quantify
what they expect to be present in the sample. These drawbacks
may be eliminated in a variation on the theme of quantiﬁcation
in the MS2 spectra recently implemented as a pipeline on fast
scanning, high resolution mass spectrometers. This approach, re-
ferred to as SWATH MS, enables sensitivity and precision similar
to that of SRM [117], but because it analyzes the entire contents
of a sample it can be re-interrogated at a later stage for any protein
or peptide of interest. We have recently shown that SWATH can be
used (similar to AP-SRM) to characterize changes in interactomes,
with the added advantage of rapidity in method building, and the
possibility to retrospectively analyze the data (Lambert et al. in
prep.). In summary, methods harnessing the quantitative power
of mass spectrometry to study interaction dynamics are becoming
more robust and sensitive, and will undoubtedly lead to an in-
crease in the number of studies producing such data. While this
is exciting, how these types of data are recorded in public reposi-
tories, and how they are displayed, will remain issues that the ﬁeld
must deal with.
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In this review, we have attempted to raise awareness for; (i) the
need to promote a better understanding of what AP-MS data can
provide, and how this type of data differs from that generated by
‘‘binary’’ detection methods, (ii) to advocate for recording quantita-
tive MS information in public repositories, and (iii) to take advan-
tage of this data to better understand protein–protein interactions.
While at the moment there is no single ‘‘winning’’ genome-scale
technique that enables structural and dynamic analyses of all types
of interactomes, many encouraging results which in principle
should be scalable are coming to the fore. One remaining challenge
will be determining how to visually and computationally represent
the multiple layers of data that will be generated by future exper-
iments focused on dynamic changes in protein–protein interac-
tions. Lastly, while computational biologists have learned to deal
with noise in interaction data (especially for making general con-
clusions regarding the behavior of a system), the systems biology
community faces a daunting task in convincing other biologists
that datasets acquired in high- or medium-throughput studies
are both of high quality and biologically meaningful. This is neces-
sary to engage the global scientiﬁc community in ﬁnally bridging
the gap between the hairball and the atomic level understanding
of protein–protein interactions.
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